• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[门静脉高压肝硬化患者的血清肾上腺素和去甲肾上腺素水平]

[Serum adrenaline and noradrenaline levels in cirrhosis patients with portal hypertension].

作者信息

Zhu J, Du R, Leng X

机构信息

Department of Surgery, People's Hospital, Beijing Medical University.

出版信息

Zhonghua Wai Ke Za Zhi. 1996 Mar;34(3):144-6.

PMID:9387666
Abstract

High Pressure Liquid chromatography was used to measure serum adrenaline (E) and noradrenaline (NE) concentrations in 38 portal hypertensive patients, 28 idiopathic hypertensive patients, and 34 controls, respectively. It was found that peripheral E in portal hypertensive patients and controls was 57.5 +/- 37.4 pg/ml and 23.5 +/- 11.2 pg/ml respectively (P < 0.01), and peripheral NE was 451.1 +/- 381.2 pg/ml and 183.0 +/- 83.3 pg/ml (P < 0.01). Compared with controls, peripheral E and NE in idiopathic hypertensive patients were also significantly increased (54.9 +/- 39.9 pg/ml vs. 23.6 +/- 11.2 pg/ml, P < 0.01, and 524.3 +/- 219.9 pg/ml vs. 183.0 +/- 83.3 pg/ml, P < 0.01). E and NE in superior vena cava (SVC), portal vein, and peripheral artery in portal hypertensive patients were also increased, but only the elevation of E in SVC was significant (207.2 +/- 55.4 pg/ml vs. 83.7 +/- 46.7 pg/ml, P < 0.05). Our results reveal significant metabolic disorders of E and NE in portal hypertensive patients, which may play an important role in the pathogenesis of portal hypertension.

摘要

采用高效液相色谱法分别测定了38例门静脉高压患者、28例特发性高血压患者和34例对照者血清肾上腺素(E)和去甲肾上腺素(NE)浓度。结果发现,门静脉高压患者和对照者外周血E分别为57.5±37.4 pg/ml和23.5±11.2 pg/ml(P<0.01),外周血NE分别为451.1±381.2 pg/ml和183.0±83.3 pg/ml(P<0.01)。与对照者相比,特发性高血压患者外周血E和NE也显著升高(54.9±39.9 pg/ml对23.6±11.2 pg/ml,P<0.01;524.3±219.9 pg/ml对183.0±83.3 pg/ml,P<0.01)。门静脉高压患者上腔静脉(SVC)、门静脉和外周动脉中的E和NE也升高,但仅SVC中E的升高具有显著性(207.2±55.4 pg/ml对83.7±46.7 pg/ml,P<0.05)。我们的研究结果揭示了门静脉高压患者E和NE存在明显的代谢紊乱,这可能在门静脉高压的发病机制中起重要作用。

相似文献

1
[Serum adrenaline and noradrenaline levels in cirrhosis patients with portal hypertension].[门静脉高压肝硬化患者的血清肾上腺素和去甲肾上腺素水平]
Zhonghua Wai Ke Za Zhi. 1996 Mar;34(3):144-6.
2
Serum levels of epinephrine and norepinephrine in cirrhotic patients with portal hypertension.
Chin Med J (Engl). 1998 Jun;111(6):504-6.
3
Plasma catecholamines in patients with presinusoidal portal hypertension: comparison with cirrhotic patients and nonportal hypertensive subjects.
Hepatology. 1991 May;13(5):913-6.
4
Effect of sympathetic and plasma renin activity on hemodialysis hypertension.交感神经与血浆肾素活性对血液透析高血压的影响。
Clin Nephrol. 2001 Feb;55(2):115-20.
5
[Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication].
Zhonghua Wai Ke Za Zhi. 1995 Sep;33(9):563-5.
6
Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors.乙型肝炎肝硬化门静脉高压性胃病与其他因素的相关性。
Hepatobiliary Pancreat Dis Int. 2002 Nov;1(4):527-31.
7
[Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].[门腔分流术手术期间门静脉高压肝硬化患者的胰高血糖素血浆水平]
Zhonghua Wai Ke Za Zhi. 1999 Apr;37(4):222-4.
8
Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients.异前列腺素F2α-III(脂质过氧化的标志物)的门静脉水平与肝硬化患者门静脉压力升高无关。
J Investig Med. 1998 Dec;46(9):430-4.
9
Plasma levels of cavernous and systemic norepinephrine and epinephrine in men during different phases of penile erection.男性阴茎勃起不同阶段时海绵体及全身去甲肾上腺素和肾上腺素的血浆水平。
J Urol. 2000 Aug;164(2):573-7.
10
Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension.
Scand J Clin Lab Invest. 1982 May;42(3):217-23.